Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000950170-25-096674

Options or other derivatives

  • Director acquired 13,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jerman Michael Allen Director 2025-07-15 Grant or award · Employee Stock Option (right to buy) +10,000 10,000 D
Jerman Michael Allen Director 2025-07-15 Grant or award · Employee Stock Option (right to buy) +3,200 3,200 D
Loading xslF345X05/ownership.xml…